289 related articles for article (PubMed ID: 30740748)
1. Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.
Dong R; Xu X; Yu L; Ding H; Pan J; Yu Y; Shi C; Chen Q; Zhang M; Lv H; Qiu Z
Aliment Pharmacol Ther; 2019 Mar; 49(6):714-722. PubMed ID: 30740748
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.
Xu XH; Yang ZM; Chen Q; Yu L; Liang SW; Lv HJ; Qiu ZM
World J Gastroenterol; 2013 Jul; 19(27):4386-92. PubMed ID: 23885151
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough.
Zhang M; Zhu Y; Dong R; Qiu Z
J Thorac Dis; 2020 Sep; 12(9):5243-5250. PubMed ID: 33145100
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical characteristics of chronic cough due to non-acid and acid gastroesophageal reflux.
Xu X; Yang Z; Chen Q; Yu L; Liang S; Lü H; Qiu Z
Clin Respir J; 2015 Apr; 9(2):196-202. PubMed ID: 24898575
[TBL] [Abstract][Full Text] [Related]
5. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
[TBL] [Abstract][Full Text] [Related]
6. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease.
Cange L; Johnsson E; Rydholm H; Lehmann A; Finizia C; Lundell L; Ruth M
Aliment Pharmacol Ther; 2002 May; 16(5):869-73. PubMed ID: 11966493
[TBL] [Abstract][Full Text] [Related]
7. Pressure and length of the lower esophageal sphincter as predictive indicators of therapeutic efficacy of baclofen for refractory gastroesophageal reflux-induced chronic cough.
Zhu Y; Xu X; Zhang M; Si F; Sun H; Yu L; Qiu Z
Respir Med; 2021 Jul; 183():106439. PubMed ID: 33962111
[TBL] [Abstract][Full Text] [Related]
8. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.
Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G
Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux--a randomised prospective study.
Cossentino MJ; Mann K; Armbruster SP; Lake JM; Maydonovitch C; Wong RK
Aliment Pharmacol Ther; 2012 May; 35(9):1036-44. PubMed ID: 22428773
[TBL] [Abstract][Full Text] [Related]
10. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms.
Pauwels A; Raymenants K; Geeraerts A; Boecxstaens V; Masuy I; Broers C; Vanuytsel T; Tack J
Aliment Pharmacol Ther; 2022 Jul; 56(2):231-239. PubMed ID: 35665521
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.
Ciccaglione AF; Marzio L
Gut; 2003 Apr; 52(4):464-70. PubMed ID: 12631652
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.
Vakil NB; Huff FJ; Cundy KC
Aliment Pharmacol Ther; 2013 Jul; 38(2):107-17. PubMed ID: 23721547
[TBL] [Abstract][Full Text] [Related]
14. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
Gallusi G; Pontone S
Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
16. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
[TBL] [Abstract][Full Text] [Related]
17. Baclofen therapy for chronic hiccup.
Guelaud C; Similowski T; Bizec JL; Cabane J; Whitelaw WA; Derenne JP
Eur Respir J; 1995 Feb; 8(2):235-7. PubMed ID: 7758557
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
[TBL] [Abstract][Full Text] [Related]
19. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.
Grossi L; Spezzaferro M; Sacco LF; Marzio L
Neurogastroenterol Motil; 2008 Jul; 20(7):760-6. PubMed ID: 18373654
[TBL] [Abstract][Full Text] [Related]
20. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.
Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
Eur Respir J; 2000 Oct; 16(4):633-8. PubMed ID: 11106204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
